Mid-market commentary: September 6, 2016
DSIJ Intelligence / 06 Sep 2016

Indian capital markets are trading with a bullish trend. BSE Sensex is up 312.73 points or 1.10 per cent at 28848.39; and the Nifty is also up 94.15 points or 1.09 per cent at 8905.2.
Indian capital markets are trading with a bullish trend. BSE Sensex is up 312.73 points or 1.10 per cent at 28848.39; and the Nifty is also up 94.15 points or 1.09 per cent at 8905.2. Nifty has breached 8900 levels after March 2015. About 1603 shares have advanced, 888 shares declined, and 170 shares are unchanged. On the sectoral front, all are trading green. Auto, Bankex are witnessing a major uptrend among others. Bank Nifty has increased almost to 18 months' high.
Meanwhile, Asian markets are trending positive at the start of the week. Shanghai is up by 0.61 per cent, Nikkei has risen by 0.26 per cent and Hang Seng has increased by 0.36 per cent on an intraday basis. Meanwhile, European indices have started positive, DAX has increased by 0.29 per cent and CAC 40 has risen by 0.23 per cent. FTSE has declined by 0.07 per cent.
WTI crude oil has increased by 1.85 per cent to USD 45.26. Brent Crude Oil also has risen by 0.19 per cent to USD 47.72.
Stocks to watch:
Sun Pharmaceutical Industries: Sun Pharmaceutical Industries has announced distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan.
Ramco Systems: Canada’s leading Aerospace & Defence In-Service Support Integrator, L-3 MAS has selected Ramco's Aviation Suite.
Pennar Engineered Building Systems: Pennar Engineered Building Systems bags orders worth Rs 203 crore.
Equitas Holdings: Equitas Holdings has started as a first time private bank operater from Tamil Nadu, post-independence.
Lupin: Lupin’s US subsidiary Gavis Pharmaceuticals has received tentative approval for its Moxifloxacin Hydrochloride tablets, 400 mg from USFDA, which is generic version of Avelox tablets.